MedTrace Logo

Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease

NCT04738474 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2025-12-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the feasibility and preliminary efficacy of the Promoting Resilience in Stress Management (PRISM) intervention in patients with adult congenital heart disease.

Conditions

  • Congenital Heart Disease

Interventions

BEHAVIORAL

Promoting Resilience in Stress Management (PRISM)

Develops personal "resilience resources" through 1:1 sessions with a PRISM coach.

OTHER

Usual Care

No additional study-specific interaction with subjects. Subjects continue to receive usual medical care.

Sponsors & Collaborators

Principal Investigators

  • Jill M Steiner, MD,MS · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2024-07-25
Completion
2024-07-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04738474 on ClinicalTrials.gov